Live Chat

CFD:er är komplexa instrument som innebär hög risk att du förlorar pengar snabbt på grund av hävstången. 74,2% av icke-professionella investerares konton förlorar pengar när de handlar med CFD:er hos den här leverantören. Du bör överväga om du förstår hur CFD:er fungerar och om du har råd att ta den höga risken att förlora dina pengar.

Close

Affär Eli Lilly LLY

Sälj
 Köp

EliLilly realtidsdiagram

5m 15m 30m 1h 4h 1d 1w

Instrumentfundament

Weekly Search
Weekly
Daily
Datum Stäng Förändring Förändring (%) Öppna Hög Låg

Senaste nyheter

FOMC meeting
Dyogenes Diniz 2025 Jan 07, 17:00

US Jobs, FOMC Minutes & Technical Insights

USD JPY AAPL
Frances Wang 2025 Jan 07, 16:00

IONQ stock update: IONQ soars to all-time high, hitting $48.61

Stocks
Frances Wang 2025 Jan 07, 16:00

Tesla stock price today: TSLA stock slides on new probe, downgrade

Stocks
USD/CHF in focus
Tommy Yap 2025 Jan 06, 17:00

Morning Note: USD/CHF Eyes Swiss Inflation; Bitcoin Soars Past $100K

USD
Eurozone services PMI
Dyogenes Diniz 2025 Jan 06, 17:00

Morning Note: PMI Readings, Inflation Trends, and Support Levels to Watch

AUD USD
Frances Wang 2025 Jan 06, 16:00

Bitcoin price today: BTC climbed above the $100K again

Cryptocurrencies
Frances Wang 2025 Jan 06, 16:00

EUR/USD Price Analysis: The EUR/USD increased over 0.78%

Forex
Frances Wang 2025 Jan 05, 16:00

Cardano Surges 25%: Cardano price prediction 2025

Cryptocurrencies

Info

Spread

4.97

Spread (%)

0.6443 %

Hävstångseffekt

1:5

Köp till dagslåneränta

-0.0597 %

Sälj till dagslåneränta

-0.0292 %

Valuta

USD

Handelstider

Marknaderna är stängda

Onsdag

14:31 - 20:59

Måndag

14:31-20:59

Tisdag

14:31-20:59

Fredag

14:31-20:59

Analys och statistik

Öppna

---

Föregående stängning

---

52 veckors högsta/lägsta

--- – ---

Marknadsvärde

703247024128

Utelöpande aktier

899315968

Rapportdatum (nästa)

1997-10-16

Utd-procent

2025-03-10

Datum efter utdelning

2025-02-14

Förväntad framtida årlig utdelningsprocent

6

Förväntad framtida årlig direktavkastning

0.0077

Vinst per aktie

9.1

Läs mer om detta instrument

Eli Lilly Eli Lilly and Company
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It operates Lilly Seaport Innovation Center (LSC), a research and development facility in the Boston Seaport to advancing Lilly's efforts in RNA and DNA-based therapies as well as discovering new drug targets to create life-changing medicines across several disease states, including diabetes, obesity, cardiovascular diseases, neurodegeneration, and chronic pain. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; Verge Genomics; and Chugai Pharmaceutical Co., Ltd, as well as development collaboration with Eli Lilly and Company for developing QIAstat-Dx IVD panel, for the detection of various APOE genotypes. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Läs mer om detta instrument

Tillgång
Sälj
Köp
Förändring (%)

Handla nu

Handla nu

Handla nu

Handla nu
Relaterade instrument
Trustpilot
Live Chat